Skip to main content
. 2016 Dec 9;37(2):123–132. doi: 10.1007/s10875-016-0359-1

Fig. 1.

Fig. 1

Flow chart showing inclusion/exclusion criteria for study participation. The number of measurements (samples) is given, together with the number of individuals/number of families below/in brackets. Treatment* refers to samples excluded (n = 93) because patients were on reverse transcriptase or JAK inhibitors

HHS Vulnerability Disclosure